The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Nordic Group
Research Funding - Nordic Group
 
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Celgene; Merck
Feasibility of switching to S-1 after other fluoropyrimidine-related cardiotoxicity during chemotherapy for solid tumors.
 
Pia J. Osterlund
Consulting or Advisory Role - Amgen; Bayer; Celgene; Eisai; Incyte; Lilly; Merck; MSD Oncology; Roche; Sanofi; Servier/Shire
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); MSD (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca (Inst); Merck (Inst); Roche (Inst)
 
Sampsa Kinos
Research Funding - Nordic Drugs (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Päivi Halonen
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - MSD; Roche; SERVIER
 
Leena-Maija Soveri
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Merck; Nordic Drugs; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Nordic Drugs; Roche
 
Johannes J Kwakman
No Relationships to Disclose
 
Tapio Salminen
No Relationships to Disclose
 
Raymond S. McDermott
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi
Speakers' Bureau - MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen-Cilag; Pfizer; Roche
 
Per Pfeiffer
Research Funding - Nordic Drugs (Inst); SERVIER (Inst)
 
Eetu Heervä
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Roche; Sanofi
 
Gabor Liposits
Honoraria - Nutricia
Consulting or Advisory Role - Nutricia
 
Rebecka Röckert
No Relationships to Disclose
 
Annika Ålgars
Consulting or Advisory Role - Amgen; Bayer; Celgene; Janssen-Cilag; Lilly; Merck; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Patents, Royalties, Other Intellectual Property - Patent US20110217296 A1 method selecting patients for treatment with an EGFR inhibitor (Inst)
Travel, Accommodations, Expenses - BMS Brazil; Merck; MSD; Varian Medical Systems
 
Raija S. Kallio
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Merck; Nordic Drugs; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Lilly (Inst); Merck (Inst); Nordic Drugs (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - MSD
 
Halfdan Sorbye
Honoraria - Bayer; Ipsen; Merck; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Keocyt; Novartis; Pfizer
Research Funding - Amgen
 
Petra Flygare
Honoraria - Roche
 
Helga Hagman
Consulting or Advisory Role - Roche
Travel, Accommodations, Expenses - Roche
 
Carl-Henrik A. Shah
Stock and Other Ownership Interests - GlaxoSmithKline
Honoraria - Nordic Drugs
Research Funding - Nordic Drugs
 
Erik D. van Werkhoven
No Relationships to Disclose
 
Bengt Glimelius
Research Funding - Swedish Cancer Society
 
Cornelis J. A. Punt
Consulting or Advisory Role - Bayer (Inst); Nordic Bioscience (Inst)
Travel, Accommodations, Expenses - Nordic Bioscience